These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19543906)

  • 21. Delineation of the vitreous and posterior hyaloid using bromophenol blue.
    Haritoglou C; Strauss R; Priglinger SG; Kreutzer T; Kampik A
    Retina; 2008 Feb; 28(2):333-9. PubMed ID: 18301040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes of triamcinolone acetonide-assisted anterior vitrectomy during complicated cataract surgery with vitreous loss.
    Bar-Sela SM; Fleissig E; Yatziv Y; Varssano D; Regenbogen M; Loewenstein A; Goldstein M
    J Cataract Refract Surg; 2014 May; 40(5):722-7. PubMed ID: 24767908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double visualization using triamcinolone acetonide and trypan blue during stage 3 macular hole surgery.
    Yamamoto N; Ozaki N; Murakami K
    Ophthalmologica; 2004; 218(5):297-305. PubMed ID: 15334009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staining of the internal limiting membrane with intravitreal triamcinolone acetonide.
    Tognetto D; Zenoni S; Sanguinetti G; Haritoglou C; Ravalico G
    Retina; 2005 Jun; 25(4):462-7. PubMed ID: 15933593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subfoveal triamcinolone acetonide following macular hole surgery.
    Jindal A; Bhawdekar A; Pathengay A
    Nepal J Ophthalmol; 2013; 5(1):114-6. PubMed ID: 23584657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detecting vitreomacular adhesions in eyes with asteroid hyalosis with triamcinolone acetonide.
    Yamaguchi T; Inoue M; Ishida S; Shinoda K
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):305-8. PubMed ID: 16411097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcomes of macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling.
    Kumagai K; Furukawa M; Ogino N; Larson E; Uemura A
    Retina; 2007; 27(9):1249-54. PubMed ID: 18046233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case of mycotic endophthalmitis after triamcinolone acetonide-assisted pars plana vitrectomy.
    Ataka S; Kurita K; Wada S; Tayeya K; Shiraki K
    Int Ophthalmol; 2007 Feb; 27(1):51-4. PubMed ID: 17393075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual triamcinolone acetonide at macular hole after vitreous surgery.
    Kumar A; Sinha S; Gupta A
    Indian J Ophthalmol; 2010; 58(3):232-4. PubMed ID: 20413928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Triamcinolone-assisted internal limiting membrane peeling.
    Shah GK; Rosenblatt BJ; Blinder KJ; Grand MG; Smith M
    Retina; 2005 Dec; 25(8):972-5. PubMed ID: 16340525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes of administration of intravitreal triamcinolone acetonide after posterior vitreous detachment during pars plana vitrectomy for proliferative diabetic retinopathy.
    Liao M; Huang Y; Wang J; Meng X; Liu Y; Yu J; Yan H
    Br J Ophthalmol; 2023 Apr; 107(4):560-564. PubMed ID: 34844917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown.
    Sakamoto T; Miyazaki M; Hisatomi T; Nakamura T; Ueno A; Itaya K; Ishibashi T
    Graefes Arch Clin Exp Ophthalmol; 2002 Jun; 240(6):423-9. PubMed ID: 12107507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double peel using triamcinolone acetonide and trypan blue in the management of myopic macular hole with retinal detachment: a case-control study.
    Li KK; Tang EW; Li PS; Wong D
    Clin Exp Ophthalmol; 2010 Oct; 38(7):664-8. PubMed ID: 20497431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term clinical outcomes and therapeutic benefits of triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy: a case study.
    Ueno A; Enaida H; Hata Y; Hisatomi T; Nakamura T; Mochizuki Y; Sakamoto T; Ishibashi T
    Eur J Ophthalmol; 2007; 17(3):392-8. PubMed ID: 17534822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema.
    Asami T; Terasaki H; Kachi S; Nakamura M; Yamamura K; Nabeshima T; Miyake Y
    Ophthalmology; 2004 Feb; 111(2):231-7. PubMed ID: 15019368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of pars plana vitrectomy with ILM peeling and intravitreal triamcinolone in diffuse diabetic macular oedema].
    Khurieva-Sattler E; Krause M; Löw U; Gatzioufas Z; Toropygin S; Seitz B; Ruprecht K; Hille K
    Klin Monbl Augenheilkd; 2010 Jun; 227(6):496-500. PubMed ID: 20221984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
    Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
    Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraocular pressure after intravitreal injection of triamcinolone acetonide following vitrectomy for macular edema.
    Yamashita T; Uemura A; Kita H; Sakamoto T
    J Glaucoma; 2007 Mar; 16(2):220-4. PubMed ID: 17473734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy.
    Furino C; Micelli Ferrari T; Boscia F; Cardascia N; Recchimurzo N; Sborgia C
    Retina; 2003 Dec; 23(6):771-6. PubMed ID: 14707825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema.
    Figueroa MS; Contreras I; Noval S
    Retina; 2008 Mar; 28(3):420-6. PubMed ID: 18327133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.